Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

Annalise VonderEmbse, PhD

Brii Biosciences

Disclosure(s): Brii Biosciences: Stocks/Bonds

Poster(s):

1282 - Safety, Tolerability, and Pharmacokinetics of BRII-732, A Medoxomil Carbonate Prodrug of Islatravir in Healthy Adult Subjects
Friday, October 21, 2022
12:15 PM – 1:30 PM US ET